Valence Labs is Recursion’s new machine learning research center that aims to promote open science and academic research. $1 million will be committed to advancing the next generation of ...

Recursion Pharmaceuticals has announced a research agreement with Sanofi Genzyme, to deploy its drug repurposing platform to identify new uses for Sanofi’s clinical stage molecules across dozens of ...